Comparison between shorter straight and thinner microtapered insulin injection needles

Diabetes Technology and Therapeutics

Volumn 15, Issue 7, 2013, Pages 550-555

  Nagai, Yoshio ^a   Ohshige, Toshihiko ^a   Arai, Kaori ^a   Kobayashi, Hidetoshi ^a   Sada, Yukiyoshi ^a   Ohmori, Shintaro ^a   Furukawa, Kentaro ^a   Kato, Hiroyuki ^a   Kawata, Takehiro ^a   Ohta, Akio ^a   Tanaka, Yasushi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED ALBUMIN; INSULIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; NEEDLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUESTIONNAIRE; STUDENT T TEST; UNIVERSITY HOSPITAL; VALIDITY; VISUAL ANALOG SCALE;

AGED; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; JAPAN; MALE; MATERIALS TESTING; MIDDLE AGED; NEEDLES; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PREFERENCE; SELF ADMINISTRATION; SERUM ALBUMIN;

EID: 84880268099     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0334     Document Type: Article

References (20)

1. Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G: A randomised, 52-week, treat-To-Target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulinnaïve people with type 2 diabetes. Diabetologia 2008;51: 408-416
2. Nathan DM: Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002;347:1342-1349
3. Gerstein HC, Yale JF, Harris SB, Issa M, Stewart JA, Dempsey E: A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet Med 2006;23: 736-742
4. Alberti G: The DAWN (Diabetes Attitudes Wishes and Needs) study. Pract Diabetes Int 2002;19:22-24
5. International DAWN Advisory Panel: Resistance to insulin therapy among patients and providers: Results of the crossnational Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-2679
6. Skovlund SE, Peyrot M: The Diabetes Attitudes, Wishes, and Needs (DAWN) Program: A new approach to improving outcomes of diabetes care. Diabetes Spectrum 2005;18: 136-142
7. Ishii H, Uchigata Y, Yoshioka N: Survey of guidance for insulin treatment [in Japanese]. Jpn J Diabetes Master Clinician 2004;2:63-71
8. Asakura T, Seino H, Nunoi K, Hashimoto K, Mutou T, Yamazaki K, Kakutani M, Toraishi K, Kitaoka M, Daikoku H, Sugiyama K, Narasaki K, Tsuji K, Ohnishi S, Oto K, Tsujimoto T, Nakano R: Usability of a microtapered needle (TN3305) for insulin treatment in Japanese patients with diabetes mellitus: A comparative clinical study with a standard thin wall needle. Diabetes Technol Ther 2006;8: 489-494
9. Schwartz S, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W: A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge • 6-mm needle versus a 29 gauge • 12.7-mm needle in obese patients with diabetes mellitus. Clin Ther 2004;26:1663-1678
10. Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L, Polak M, Kakou B, Leridon L, Hassan M, Czernichow P: Short needles (8mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care 1999;22: 1621-1625
11. Hirsch LJ, Gibney MA, Albanese J, Qu S, Kassler-Taub K, Klaff LJ, Bailey TS: Comparative glycemic control, safety and patient ratings for a new 4mm• 32 G insulin pen needle in adults with diabetes. Curr Med Res Opin 2010;26:1531-1541
12. Gibney MA, Arce CH, Byron KJ, Hirsch LJ: Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: Implications for needle length recommendations. Curr Med Res Opin 2010;26:1519-1530
13. Laurent A, Mistretta F, Bottigioli D, Dahel K, Goujon C, Nicolas JF, Hennino A, Laurent PE: Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007;25:6423-6430
14. Egekvist H, Bjerring P, Arendt-Nielsen L: Pain and mechanical injury of skin following mechanical needle insertions. Eur J Pain 1999;3:41-49
15. Arendt-Nielsen L, Egekvist H, Bjerring P: Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res 2006;23:37-43
16. Iwanaga M, Kamoi K: Patient perceptions of injection pain and anxiety: A comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles. Diabetes Technol Ther 2009;11:81-86
17. McKay M, Compion G, Lytzen L: A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: A randomized, open-label, crossover study in subjects with diabetes. Diabetes Technol Ther 2009;11: 195-201
18. Miwa T, Itoh R, Kobayashi T, Tanabe T, Shikuma J, Takahashi T, Odawara M: Comparison of the effects of a new 32-gauge • 4-mm pen needle and a 32-gauge • 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetes. Diabetes Technol Ther 2012;14:1084-1090
19. Siegmund T, Blankenfeld H, Schumm-Draeger P-M: Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: An open-label study. Diabetes Technol Ther 2009;11:523-528
20. Sugiyama K, Oizumi T, Abe T: Insulin flow in different needles for pen-Type syringe [in Japanese]. Practice 1999;16: 437-439